US Patent Issued to Novo Nordisk on Feb. 18 for "Glucose-sensitive albumin-binding derivatives" (Czech, Danish Inventors)

ALEXANDRIA, Va., Feb. 19 -- United States Patent no. 12,227,528, issued on Feb. 18, was assigned to Novo Nordisk A/S (Bagsvaerd, Denmark).

"Glucose-sensitive albumin-binding derivatives" was invented by Thomas Kruse (Herlev, Denmark), Mikael Kofod-Hansen (Broenshoej, Denmark), Martin Werner Borchsenius Muenzel (Broenshoej, Denmark), Henning Thoegersen (Farum, Denmark), Per Sauerberg (Farum, Denmark), Jakob Ewald (Koebenhavn N, Denmark), Carsten Behrens (Koebenhavn N, Denmark), Thomas Hoeg-Jensen (Broenshoej, Denmark), Vojtech Balsanek (Prague), Zuzana Drobnakova (Prague), Ladislav Droz (Prague), Miroslav Havranek (Prague), Vladislav Kotek (Prague), Milan Stengl (Klatovy, Czech Republic), Ivan Snajdr (Prague) and Hana Drusanova (Kromeriz, C...